NEW YORK (GenomeWeb) – Genomic data firm PierianDx today announced it is exclusively licensing a proprietary genetic testing tool and processes from Washington University in St. Louis.
PierianDx will offer the tool, called the Clinical Genomicist Workstation, to other clinical labs "giving them an end-to-end solution for managing clinical next-generation sequencing processes." CGW is a software platform for NGS clinical tests that manages data and workflow, the St. Louis-based company said on its website.
Along with the CGW software, PierianDx offers an IT backbone, integrated processes, access to a bioinformatics database, and consulting services. Washington University will continue to have access to PierianDx's technology for use in its clinical practice and research.
Financial and other terms of the deal were not disclosed.